| Literature DB >> 35663248 |
Fufa Abunna1, Biyansa Adugna2, Takele Beyene Tufa1, Dinka Ayana1, Fanta D Gutema1, Hika Waktole1, Fikru Regassa1, Reta D Abdi3.
Abstract
Background: In veterinary medicine, three Staphylococcus species are of particular importance as primary causes of specific diseases; S. aureus (mastitis in ruminants, equine botryomycosis, and bumble foot in poultry), S. hycus (porcine exudative epidermitis), and S. intermedius (canine pyoderma). The disease conditions caused by Staphylococcus in poultry vary with site, route, and predisposing factors include wounds as a result of fighting/cannibalism, immunosuppression based on virus infection or parasite infestation, and bad husbandry conditions (overcrowding). The objectives of this study were to isolate and identify Staphylococcus spp from chicken and chicken litter and personnel at chicken farm and to determine the antimicrobial susceptibility profile of the isolates.Entities:
Year: 2022 PMID: 35663248 PMCID: PMC9159885 DOI: 10.1155/2022/9084334
Source DB: PubMed Journal: Vet Med Int ISSN: 2042-0048
Distribution of Staphylococcus isolates in different farms, housing systems, sample source, and sample types.
| Positive | Total | Prevalence (%) | 95%CI |
|
| ||
|---|---|---|---|---|---|---|---|
| Farm name | M | 4 | 22 | 18.18 | 16.40, 19.96 | 11.92 | 0.046 |
| D | 21 | 59 | 35.59 | 34.07, 37.12 | |||
| U | 10 | 28 | 35.71 | 33.50, 37.93 | |||
| M | 14 | 62 | 22.58 | 21.40, 23.76 | |||
| A | 11 | 23 | 47.83 | 45.00, 50.65 | |||
| E | 4 | 28 | 14.29 | 12.89, 15.69 | |||
|
| |||||||
| Housing system | C | 4 | 28 | 14.29 | 12.89, 15.69 | 3.30 | 0.07 |
| L | 60 | 194 | 30.93 | 30.15, 31.71 | |||
|
| |||||||
| Sample source | B | 45 | 134 | 33.58 | 32.60, 34.56 | 7.72 | 0.052 |
| L | 7 | 17 | 41.18 | 38.13, 4.23 | |||
| Ly | 10 | 57 | 17.54 | 16.46, 18.63 | |||
| P | 2 | 14 | 14.29 | 12.31, 16.27 | |||
|
| |||||||
| Sample type | C | 33 | 101 | 32.67 | 31.56, 33.79 | 5.67 | 0.225 |
| HB | 0 | 7 | 0.00 | — | |||
| L | 7 | 17 | 41.18 | 38.13, 44.23 | |||
| N | 2 | 7 | 28.57 | 24.61, 32.53 | |||
| T | 22 | 90 | 24.44 | 23.42, 25.47 | |||
| Total | 64 | 222 | 28.83 | 28.12, 29.54 | |||
Keys: AM = Amelewerk farm enterprise; BD = Bayissa Damessa farm; EU = Europe farm enterprise; HM = Haile Michael farm; SA = Senait and Abdella and their friends; TE = Tesfaye farm enterprise; C = cage type housing system; L = litter type housing system; P = personnel, Ly = layer, B = broiler, Cl = cloacal swab; L = litter swab, T = tracheal swab; N = nasal swab; HB = hand and boot swab.
The proportional distribution of Staphylococcus species isolated from different farms, housing systems, sample sources, and different sample types.
|
| |||||
|---|---|---|---|---|---|
| CNS | SA | SH | SI | ||
| Farm name | AM ( | 0 (0.0) | 4 (18.2) | 0 (0.0) | 0 (0.0) |
| BD ( | 0 (0.0) | 19 (32.2) | 2 (3.4) | 0 (0.00 | |
| EU ( | 4 (14.3) | 2 (7.1) | 3 (10.7) | 1 (3.6) | |
| HM ( | 3 (4.8) | 10 (16.1) | 0 (0.0) | 1 (1.6) | |
| SA ( | 3 (13) | 1 (3.4) | 6 (26.1) | 1 (4.3) | |
| TE ( | 0 (0.0) | 4 (14.3) | 0 (0.0) | 0 (0.0) | |
|
| |||||
|
| 15.28 (0.01) | 13.60 (0.02) | 29.93 (0.00) | 4.12 (0.53) | |
|
| |||||
| Housing system | C ( | 0 (0.0) | 4 (14.3) | 0 (0.0) | 0 (0.00 |
| L ( | 10 (5.2) | 36 (18.6) | 11 (5.7) | 3 (1.6) | |
|
| |||||
|
| 2.30 (0.32) | 0.32 (0.88) | 2.55 (0.29) | 0.67 (0.72) | |
|
| |||||
| Sample source | B ( | 9 (6.7) | 24 (17.9) | 9 (6.7) | 3 (2.2) |
| L ( | 1 (5.9) | 4 (23.5) | 2 (11.8) | 0 (0.0) | |
| Ly ( | 0 (0.0) | 10 (17.5) | 0 (0.00 | 0 (0.0) | |
| P ( | 0 (0.0) | 2 (14.3) | 0 (0.0) | 0 (0.0) | |
|
| |||||
|
| 4.95 (0.18) | 0.50 (0.92) | 6.26 (0.10) | 2.00 (0.57) | |
|
| |||||
| Sample type | C ( | 9 (8.9) | 13 (12.9) | 8 (7.9) | 3 (3) |
| HB ( | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
| L ( | 1 (5.9) | 4 (23.5) | 2 (11.8) | 0 (0.0) | |
| N ( | 0 (0.0) | 2 (28.6) | 0 (0.0) | 0 (0.0) | |
| T ( | 0 (0.0) | 21 (23.3) | 1 (1.1) | 0 (0.0) | |
|
| |||||
|
| 9.54 (0.05) | 5.95 (0.20) | 7.11 (0.13) | 3.64 (0.46) | |
|
| |||||
| Total |
| 10 (15.6) | 40 (62.5) | 11 (17.2) | 3 (4.7) |
Key: CNS = coagulase negative Staphylococcus; SA = S. aureus; SH = S. hycus; SI = S. intermedius; χ2 = chi-square, P = P value, CI = confidence interval, and C = cage type housing system; L = litter-type housing system; P = personnel, Ly = layer, B = broiler, and Cl = loacal swab; L = litter swab and T = tracheal swab; N = nasal swab; HB = hand and boot swab.
Antimicrobial susceptibility profile of staphylococcal isolates (n = 64).
| S( | Antimicrobials | Number of tested | Susceptible [ | Intermediate [ | Resistance [ |
|---|---|---|---|---|---|
| 1 | P | 64 | 2 (3.1) | 0 (0.0) | 62 (96.9) |
| 2 | VA | 64 | 26 (40.6) | 0 (0.0) | 38 (59.4) |
| 3 | CIP | 64 | 61 (95.3) | 0 (0.0) | 3 (4.7) |
| 4 | SXT | 64 | 55 (85.90 | 0 (0.0) | 9 (14.1) |
| 5 | AML | 64 | 22 (34.4) | 0 (0.0) | 42 (65.6) |
| 6 | F | 64 | 19 (29.70 | 27 (42.2) | 18 (28.1) |
| 7 | E | 64 | 6 (9.4) | 16 (25.0) | 42 (65.6) |
| 8 | TE | 64 | 7 (10.9) | 7 (10.9) | 50 (78.1) |
| 9 | S | 64 | 24 937.5) | 16 (25.0) | 24 (37.5) |
| 10 | NA | 64 | 48 (75.0) | 5 (7.80) | 11 (17.2) |
| Total | 10 | 640 | 270 (42.2) | 71 (11.1) | 299 (46.7) |
Key: P = penicillin, AML = amoxicillin, F = cefoxitin, CIP = ciprofloxacin, NA = naldixic acid, S = streptomycin, SXT = sulfamethoxazole trimethoprim, VA = vancomycin, TE = tetracycline, and E = erythromycin.
Antimicrobial susceptibility patterns of Staphylococcus species.
| Antimicrobials tested |
| ||||||
|---|---|---|---|---|---|---|---|
| CNS | SA | SH | SI |
|
| ||
| P | R ( | 10 (100) | 38 (95.0) | 11 (100) | 3 (100) | 1.239 | 0.744 |
| S ( | 0 (0.0) | 2 (5.0) | 0 (0.0) | 0 (0.0) | |||
|
| |||||||
| VA | R ( | 5 (50.0) | 29 (72.5) | 4 (36.4) | 0 (0.0) | 10.02 | 0.018 |
| S ( | 5 (50.0) | 11 (27.5) | 7 (63.6) | 3 (100) | |||
|
| |||||||
| CIP | R ( | 0 (0.0) | 1 (2.5) | 1 (9.1) | 1 (33.3) | 6.908 | 0.075 |
| S ( | 10 (100) | 39 (97.5) | 10 (90.9) | 2 (66.7) | |||
|
| |||||||
| SXT | R ( | 2 (20.0) | 5 (12.5) | 0 (0.0) | 2 (66.7) | 9.042 | 0.029 |
| S ( | 8 (80.0) | 35 (87.5) | 11 (100) | 1 (33.3) | |||
|
| |||||||
| AML | R ( | 8 (80.0) | 26 (65.0) | 5 (45.5) | 3 (100) | 4.478 | 0.214 |
| S ( | 2 (20.0) | 14 (35.0) | 6 (54.5) | 0 (0.0) | |||
|
| |||||||
| F | I ( | 1 (10.0) | 21 (52.5) | 5 (45.5) | 0 (0.0) | 16.032 | 0.014 |
| R ( | 7 (70.0) | 6 (15.0) | 4 (36.4) | 1 (33.3) | |||
| S ( | 2 (20.0) | 13 (32.5) | 2 (18.2) | 2 (66.7) | |||
|
| |||||||
| E | I ( | 1 (10.0) | 0 (0.0) | 0 (0.0) | 1 (33.3) | 20.119 | 0.003 |
| R ( | 9 (90.0) | 25 (62.5) | 7 (63.6) | 1 (33.3) | |||
| S ( | 0 (0.0) | 1 (2.5) | 4 (36.4) | 1 (33.3) | |||
|
| |||||||
| TE | I ( | 0 (0.0) | 7 (17.5) | 0 (0.0) | 0 (0.0) | 5.642 | 0.465 |
| R ( | 9 (90.0) | 29 (72.5) | 9 (81.8) | 3 (100) | |||
| S ( | 1 (10.0) | 4 (10.0) | 2 (18.2) | 0 (0.0) | |||
|
| |||||||
| S | I ( | 2 (20.0) | 11 (27.5) | 3 (27.3) | 0 (0.0) | 7.27 | 0.297 |
| R ( | 4 (40.0) | 15 (37.5) | 2 (18.2) | 3 (100) | |||
| S ( | 4 (40.0) | 14 (35.0) | 6 (54.5) | 0 (0.0) | |||
|
| |||||||
| NA | I ( | 0 (0.0) | 4 (10.0) | 1 (9.1) | 0 (0.0) | 4.931 | 0.553 |
| R ( | 3 (30.0) | 4 (10.0) | 3 (27.3) | 1 (33.3) | |||
| S ( | 7 (70.0) | 32 (80.0) | 7 (63.6) | 2 (66.7) | |||
| Total | 10 (15.6) | 40 (62.5) | 11 (17.2) | 3 (4.7) | |||
Note. I = intermediate, R = resistant, and S = susceptible.
Number and percentages of antimicrobial resistance patterns of Staphylococcus species.
| No. of antimicrobials | Antimicrobial resistance pattern | Number (%) | Species |
|---|---|---|---|
| One | NA | 1 (1.56) | SH |
| P | 1 (1.56) | SA | |
| Three | P, E, S(1); P, AML, TE (1); P, E, TE(1); P, VA, TE (2); P, F, E (1); P, VA, E (1) | 7 (10.94) | SA |
| P, AML, TE(1) P, E, TE(1) | 2 (3.13) | SH | |
| Four | P, AML, E, TE (2); P, CIP, AML, NA (1) P, E, TE, NA (1) | 4 (6.25) | SH |
| P, AML, F, TE (1); P, AML, E, S (1) | 2 (3.13) | CNS | |
| P, AML, F, TE (1); P, VA, AML, TE (2); P, VA, AML, E (5); P, VA, E, S (1); P, VA, TE, S (1) P, E, TE, S (1) | 11 (17.19) | SA | |
| Five | P, CIP, AML, TE, E (1) | 1 (1.56) | SI |
| P, VA, F, E, TE (2); | 2 (3.13) | SH | |
| P, AML, F, E, TE (1); P, VA, AML, E, TE(1); P, VA, E, TE, NA (1) | 3 (4.69) | CNS | |
| P, AML, F, E, TE (1); P, VA, AML, E, TE(4); P, VA, SXT, AML, TE (1); P, VA, AML, TE, S (2); P, VA, TE, S, NA (1); P, VA, E, TE, S (1); P, AML, F, TE, S (1) | 11 (17.19) | SA | |
| Six | P, SXT, AML, E, TE, S (1); | 1 (1.56) | SI |
| P, VA, F, E, TE, S (1); | 1 (1.56) | SH | |
| P, VA, AML, F, E, TE (1); P, AML, F, E, TE, NA (1) | 2 (3.13) | CNS | |
| P, SXT, AML, E, TE, S (1); P, VA, AML, F, E, TE (1); P, VA, SXT, E, TE, S (1); P, VA, SXY, AML, TE, S (1); P, VA, AML, E, TE, S (2) | 6 (9.380) | SA | |
| Seven | P, SXT, AML, F, TE, S, NA (1); | 1 (1.56) | SI |
| P, VA, AML, F, TE, S, NA (1); | 1 (1.56) | SH | |
| P, SXT, AML, F, E, TE, S (1) P, VA, AML, F, E, TE, S (1); | 2 (3.13) | CNS | |
| P, VA, AML, F, E, TE, S (1); P, VA, SXT, AML, E, TE, NA (1); P, VA, CIP, AML, E, TE, NA (1) | 3 (4.69) | SA | |
| Eight | P, VA, SXT, F, E, TE, S, NA(1) | 1 (1.56) | CNS |
| Total | Monoresistance (2) | 63 (98.44) | SA (39) |
| SH (11) | |||
| SI (3) | |||
| CNS (10) | |||
| MDR | 61 | 61 (95.31) | SA (38) |
| SH (10) | |||
| SI (3) | |||
| CNS (10) |
Key: MDR = multidrug resistance, SA = S. aureus, SH = S. hycus, and SI = S. intermedius.